People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Altheus Therapeutics Inc | — | Biotechnology | Series A | $33.3M | $292.3M | 2009 |
Dennis L Schafer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dennis L Schafer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Paiva | 1 | 6 |
| Douglas A. Branch | 1 | 5 |
| William A Paiva | 1 | 2 |
| Dennis Schafer | 1 | 1 |
| Richard F. Harty, MD | 1 | 1 |
| William L. Paiva | 1 | 1 |
| Brian L. Clevinger | 1 | 1 |
| James L Schoeneck | 1 | 1 |
| James Schoeneck | 1 | 1 |
| Dayton T. Reardan | 1 | 1 |
| Thomas L. Shoaf | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.